National Cancer Institute - U.S. National Institutes of Health - www.cancer.govSkip navigationNational Cancer Institute - U.S. National Institutes of Health - www.cancer.govClinical Trials at NIH - Be part of the cure
National Cancer Institute - U.S. National Institutes of Health - www.cancer.gov
Clinical Trials at NIH Home

Investigator Profiles

David S. Schrump, M.D.

David Schrump, M.D.

Thoracic Oncology Section, Surgery Branch
Clinical Head and Senior Investigator

National Cancer Institute
Building 10, Room 4-3940
Bethesda, MD 20892

Phone: 301-496-2128
Fax: 301-451-6934
David_Schrump@nih.gov


Dr. Schrump graduated from the University of Connecticut School of Medicine and completed his general surgery residency at the University of Chicago as well as a 3-year research fellowship in human cancer immunology at Memorial Sloan-Kettering Cancer Center. Following completion of his thoracic surgery residency at the University of Michigan in 1993, Dr. Schrump was appointed to the cardiothoracic surgery faculty at M. D. Anderson Cancer Center. In 1997, he was appointed Head of Thoracic Oncology, Surgery Branch, NCI. He received NIH tenure in 2006. In 1997, he was appointed Head of Thoracic Oncology, Surgery Branch, NCI. He received NIH tenure in 2006. He received an MBA in health services management from the Carey School of Business, Johns Hopkins University in 2009. He is a member of the American Association for Thoracic Surgery, Society of Thoracic Surgeons, John Alexander Society, International Association for the Study of Lung Cancer, Society of Clinical Oncologists, and the American Association for Cancer Research.

Dr. Schrump’s clinical interests include surgical management of complex thoracic malignancies, and his translational research efforts are focused on epigenetic mechanisms of gene expression in thoracic malignancies and the utilization of chromatin remodeling agents for the treatment of these neoplasms.

Dr. Schrump's Clinical Trial(s):

NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with lung cancer, thymoma/thymic carcinoma, malignant mesothelioma, esophageal cancer, or metastases to the lungs/pleura. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.

Back to Top
Health and Human Services National Institutes of Health National Cancer Institute USA.gov